Advertisement
Pearls

Innate Immune Sensing of Flaviviruses

  • Mehul S. Suthar mail,

    msuthar@emory.edu

    Affiliation: Department of Pediatrics and Children's Healthcare of Atlanta and Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, United States of America

    X
  • Sebastian Aguirre,

    Affiliation: Department of Microbiology and the Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America

    X
  • Ana Fernandez-Sesma

    Affiliation: Department of Microbiology and the Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America

    X
  • Published: September 12, 2013
  • DOI: 10.1371/journal.ppat.1003541
  • Published in PLOS Pathogens

Overview

Mosquito-borne flaviviruses cause annual epidemics of encephalitis and viscerotropic disease worldwide. West Nile virus (WNV), a member of the Japanese Encephalitis virus (JEV) antigenic complex, is a major cause of viral encephalitis throughout the world [1]. In the United States, WNV has been estimated to cause more than 3 million infections, resulting in over 780,000 illnesses, 30,000 confirmed cases, and 1,100 deaths between 1999–2013 [2]. In contrast, dengue virus (DENV) is a major cause of virus-induced viscerotropic disease, with an estimated 50 to 100 million people infected each year and a total of 2.5 billion people worldwide are at risk of infection. There are currently no approved antiviral therapies or vaccines to combat or prevent WNV or DENV infection. WNV and DENV are closely related flaviviruses that are enveloped and possess a single strand positive-sense RNA genome of approximately 11 kb in length. The genome is comprised of three structural proteins (C, prM/M, and E), which mediate virus attachment, entry, and encapsidation and seven non-structural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5), which form the replication complex to synthesize viral RNA (as reviewed in [3]). The NS proteins, including the viral RNA-dependent RNA polymerase NS5, form a replication complex that synthesizes negative-sense RNA intermediates, which subsequently serve as the template for synthesis of positive-sense RNA. The newly synthesized viral RNA is encapsidated, transported through the host secretory pathway, and released from the infected cell by exocytosis. The entire viral life cycle takes place within the cytoplasm. To combat infection, the host encodes pattern recognition receptors (PRR), residing within the cytoplasm and endosomal vesicles, which recognize pathogen-associated molecular patterns (PAMPs) and trigger inflammation and antiviral immune responses (Figure 1). Defining how viruses are sensed and the antiviral programs that are initiated to restrict virus replication have been areas of intense investigation over the past several years. In this article, we discuss contemporary research findings on how flaviviruses are “sensed” by the host pattern recognition receptors and highlight a few outstanding questions on the mechanisms underlying host immune sensing and viral countermeasures.

thumbnail

Figure 1. Innate immune sensing pathways.

(A) Following non-self RNA binding, RIG-I and MDA5 undergo a conformational change, multimerize, and interact with MAVS through CARD-CARD interactions. This activates the adaptor STING and latent transcription factors IRF-3, IRF-7, and NF-κB to induce expression of IFN-β and IRF-3 target genes; (B) Within the endosomal compartment, TLR3 and TLR7 bind to non-self RNA, interact with their adaptor proteins, and activate IRF-3, IRF-7, and NF-κB dependent gene expression; (C) Upon detection of viral dsRNA or cellular stress signals, the NLPR3 oligomerizes, interacts with ASC, leading to activation of caspase-1 and IL-1β processing. The signaling events and host factors targeted by WNV and DENV proteins are shown.

doi:10.1371/journal.ppat.1003541.g001

Do Flaviviruses Activate the RIG-I Like Receptors?

The retinoic-acid inducible gene-I (RIG-I)-like receptors (RLRs) are cytosolic innate immune PRRs that recognize non-self RNA signatures, interact with the mitochondrial antiviral signaling protein (MAVS), and induce type I interferon (IFN), proinflammatory cytokines, and expression of IFN-stimulated genes (ISGs) (as reviewed in [4]). RIG-I and myeloma differentiation factor 5 (MDA5) are critical for detecting and responding to WNV, DENV, and other mosquito-borne flaviviruses [5], [6]. WNV infection of RIG-I−/− or MDA5−/− mouse embryonic fibroblasts revealed that RIG-I is activated early during infection whereas MDA5 is required for enhancing and sustaining type I IFN and ISG expression in response to infection [6]. Furthermore, in vivo studies have demonstrated that RLR signaling is required for protection as well as controlling peripheral organ and central nervous system (CNS) viral burden, limiting virus-mediated CNS pathology, and programming protective immunity to WNV infection [7], [8]. Similarly, RIG-I, MDA5 and MAVS, and the adaptor protein stimulator of the IFN gene (STING) are required for mediating antiviral host signaling in response to DENV infection [9], [10]. Although these receptors have been implicated in detecting and responding to flavivirus infection, it is not yet clear as to what accounts for the temporal activation of RIG-I and MDA5. Moreover, it will be interesting to determine whether the individual RLRs are functionally redundant or direct distinct antiviral programs during flavivirus infection.

What Is the Nature of the RIG-I and MDA5 PAMP?

Biochemical and molecular analysis of RIG-I and MDA5 has revealed important RNA signatures that are critical for engagement and activation of signaling. RIG-I engages short double-strand RNA (dsRNA) possessing a 5′ triphosphate and uridine- or adenosine-rich motifs (as reviewed in [4]). MDA5, on the other hand, does not require a 5′ triphosphate but preferentially engages long dsRNA. Flavivirus contain genomic RNA contains a 5′ cap structure,, which methylated, which likely prevents RIG-I recognition of the incoming viral RNA following infection. Indeed, Fredericksen and colleagues have shown that the incoming genomic RNA is not capable of activating RLR signaling but viral RNA synthesis is required for triggering IRF-3 activation, suggesting that RIG-I and MDA5 likely engage replication intermediates generated during viral RNA synthesis [11]. In support of this hypothesis, Shipley and colleagues have recently determined that in vitro transcribed RNAs corresponding to distinct regions within the positive- and negative-sense WNV RNA can trigger RIG-I activation [12], although the precise immunostimulatory nucleic acid sequence or motif has not yet been determined. During viral RNA synthesis, the positive-sense RNA strand is believed to cyclize through long distance interactions between conserved sequences within the 5′ and 3′ untranslated regions [13]. It is possible that RIG-I or MDA5 may directly interact with this viral RNA structure. Alternatively, this could be a source of dsRNAs containing a 5′ triphosphate, possibly from nascent negative-sense RNAs, or a source of long dsRNAs from newly synthesized full-length positive-sense and negative-sense viral RNAs. It is also possible that genomic RNA degradation products [14] or RNaseL cleavage products [15] promote RIG-I activation during flavivirus infection. Nonetheless, further investigation is warranted to determine the exact flavivirus PAMP RNA substrate and nucleic acid sequence that is engaged by either RIG-I and MDA5.

How Do Flaviviruses Counteract RLR Signaling?

WNV, and likely DENV, passively evade RLR activation at early times during infection [11]; however, the underlying mechanisms are not well understood. During flavivirus infection, RNA replication complexes are found within vesicle pockets, which contain nonstructural viral proteins, de novo synthesized RNA, and dsRNA intermediates [16][18]. It is possible that early during infection, these compartments sequester viral RNA replication intermediates to avoid activating RIG-I or MDA5 signaling. At later times during infection, the abundance of newly synthesized viral RNA, combined with a loss of compartment integrity, likely leads to RLR activation and innate immune signaling [11]. Unlike WNV, DENV actively inhibits type I IFN production in DCs and monocytes [19]. The viral NS2B3 protease, which normally processes the viral polyprotein, directly cleaves and degrades human STING, thus rendering RLR signaling inactive. Murine STING cannot be degraded by the DENV NS2B3 protease and could be a strong restriction factor for DENV replication in mice [10]. It is not yet clear whether STING cleavage is unique to DENV infection or a common mechanism employed by other flaviviruses. These studies also raise the intriguing possibility that other host proteins could also be targets of virus-mediated cleavage.

What Role Do the TLRs Play in Immunity to Flavivirus Infection?

The toll-like receptors (TLRs) reside within endosomal vesicles, and upon binding PAMP RNA (TLR3- dsRNA, TLR7-ssRNA), induce type I IFN and proinflammatory cytokine expression [20]. TLR3, TLR7, and the Myd88 adaptor protein are required for protection against WNV infection (as reviewed in [3]). Although the exact viral PAMP has not yet been identified, in vivo studies with WNV have shown that TLR3 and TLR7 are important for promoting CNS immunity and controlling virus replication. In response to DENV infection, experimental evidence also suggests that TLR3 is important in restricting virus replication [21]. WNV NS1, which is secreted from infected cells, is believed to antagonize TLR3 signaling [22]. This finding, however, is controversial as a follow-up study by Bartoni and colleagues failed to observe inhibition of TLR3 signaling by NS1 protein from WNV, DENV, or Yellow Fever virus [23]. Overall, the flavivirus-host interactions with the TLRs are poorly understood and further investigation is needed to better understand the cell autonomous role of TLR signaling as well as determine whether flaviviruses directly antagonize TLR signaling.

Is the Inflammasome Important?

The Nod-like receptors (NLRs) detect “danger signals” within the cellular environment, leading to formation of the inflammasome signaling complex and secretion of pro-inflammatory cytokines of the IL-1β family, including IL-1β, IL-18, and IL33 (as reviewed in [24]). WNV and DENV infection of humans is associated with elevated levels of systemic IL-1β, suggesting that viral infection activates inflammasome signaling [25][27]. Indeed, the NLRP3 inflammasome is activated following WNV and DENV infection [25], [28]. However, the exact danger signal that activates “signal 1,” which is responsible for triggering pro-IL-1β expression, or “signal 2,” which promotes IL-1β maturation, is not well understood. Further studies are needed to determine what role, if any, viral dsRNA or virus-induced cell stress signals trigger activation of the NLRP3 inflammasome during WNV and DENV infection.

During WNV infection, IL-1β is believed to mediate protection through several mechanisms, including regulating CD8+ T cell effector functions [25], regulating DC immune responses within the brain [29], controlling neuronal cell death [30], and triggering antiviral effector gene expression in neurons [25]. With relation to DENV, macrophages are believed to be the primary source of IL-1β production; however, much remains to be understood about IL-1 signaling in the context of DENV infection [28].

Summary

Emerging mosquito-borne flavivirus infections of humans continue to be a significant problem worldwide. It is becoming increasingly evident that development of effective vaccines, which provide life-long sterilizing immunity to viral infection, requires a proper understanding of how the host innate immune sensing pathways detect viral infection and program protective immunity. Continued studies to understand the flavivirus-host interactions with PRR pathways will provide valuable insights to overcome current challenges that have hindered effective vaccine development and prophylactic treatment strategies to prevent or combat WNV and DENV infection.

Acknowledgments

We thank Irene Ramos for her help in the design of the figures.

References

  1. 1. Rust RS (2012) Human arboviral encephalitis. Semin Pediatr Neurol 19: 130–151. doi: 10.1016/j.spen.2012.03.002
  2. 2. Petersen LR, Carson PJ, Biggerstaff BJ, Custer B, Borchardt SM, et al. (2012) Estimated cumulative incidence of West Nile virus infection in US adults, 1999–2010. Epidemiol Infect 1–5. doi: 10.1017/s0950268812001070
  3. 3. Suthar MS, Diamond MS, Gale M Jr (2013) West Nile virus infection and immunity. Nat Rev Microbiol 11: 115–128. doi: 10.1038/nrmicro2950
  4. 4. Loo YM, Gale M Jr (2011) Immune signaling by RIG-I-like receptors. Immunity 34: 680–692. doi: 10.1016/j.immuni.2011.05.003
  5. 5. Nasirudeen AM, Wong HH, Thien P, Xu S, Lam KP, et al. (2011) RIG-I, MDA5 and TLR3 synergistically play an important role in restriction of dengue virus infection. PLoS Negl Trop Dis 5: e926 doi:10.1371/journal.pntd.0000926.
  6. 6. Fredericksen BL, Keller BC, Fornek J, Katze MG, Gale M Jr (2008) Establishment and maintenance of the innate antiviral response to West Nile virus involves both RIG-I and MDA5 signaling through IPS-1. J Virol 82: 609–616. doi: 10.1128/jvi.01305-07
  7. 7. Suthar MS, Ma DY, Thomas S, Lund JM, Zhang N, et al. (2010) IPS-1 is essential for the control of West Nile virus infection and immunity. PLoS Pathog 6: e1000757 doi:10.1371/journal.ppat.1000757.
  8. 8. Suthar MS, Brassil MB, Blahnik G, McMillan A, Ramos HJ, et al. (2013) A systems biology approach reveals that tissue tropism to West Nile virus is regulated by antiviral genes and innate immune cellular processes. PLoS Pathog 9: e1003168 doi:10.1371/journal.ppat.1003168.
  9. 9. Perry ST, Prestwood TR, Lada SM, Benedict CA, Shresta S (2009) Cardif-mediated signaling controls the initial innate response to dengue virus in vivo. J Virol 83: 8276–8281. doi: 10.1128/jvi.00365-09
  10. 10. Aguirre S, Maestre AM, Pagni S, Patel JR, Savage T, et al. (2012) DENV inhibits type I IFN production in infected cells by cleaving human STING. PLoS Pathog 8: e1002934 doi:10.1371/journal.ppat.1002934.
  11. 11. Fredericksen BL, Gale M Jr (2006) West Nile virus evades activation of interferon regulatory factor 3 through RIG-I-dependent and -independent pathways without antagonizing host defense signaling. J Virol 80: 2913–2923. doi: 10.1128/jvi.80.6.2913-2923.2006
  12. 12. Shipley JG, Vandergaast R, Deng L, Mariuzza RA, Fredericksen BL (2012) Identification of multiple RIG-I-specific pathogen associated molecular patterns within the West Nile virus genome and antigenome. Virology 432: 232–238. doi: 10.1016/j.virol.2012.06.009
  13. 13. Zhang B, Dong H, Stein DA, Iversen PL, Shi PY (2008) West Nile virus genome cyclization and RNA replication require two pairs of long-distance RNA interactions. Virology 373: 1–13. doi: 10.1016/j.virol.2008.01.016
  14. 14. Funk A, Truong K, Nagasaki T, Torres S, Floden N, et al. (2010) RNA structures required for production of subgenomic flavivirus RNA. J Virol 84: 11407–11417. doi: 10.1128/jvi.01159-10
  15. 15. Malathi K, Saito T, Crochet N, Barton DJ, Gale M Jr, et al. (2010) RNase L releases a small RNA from HCV RNA that refolds into a potent PAMP. RNA 16: 2108–2119. doi: 10.1261/rna.2244210
  16. 16. Welsch S, Miller S, Romero-Brey I, Merz A, Bleck CK, et al. (2009) Composition and three-dimensional architecture of the dengue virus replication and assembly sites. Cell Host Microbe 5: 365–375. doi: 10.1016/j.chom.2009.03.007
  17. 17. Gillespie LK, Hoenen A, Morgan G, Mackenzie JM (2010) The endoplasmic reticulum provides the membrane platform for biogenesis of the flavivirus replication complex. J Virol 84: 10438–10447. doi: 10.1128/jvi.00986-10
  18. 18. Mackenzie JM, Jones MK, Young PR (1996) Immunolocalization of the dengue virus nonstructural glycoprotein NS1 suggests a role in viral RNA replication. Virology 220: 232–240. doi: 10.1006/viro.1996.0307
  19. 19. Rodriguez-Madoz JR, Bernal-Rubio D, Kaminski D, Boyd K, Fernandez-Sesma A (2010) Dengue virus inhibits the production of type I interferon in primary human dendritic cells. J Virol 84: 4845–4850. doi: 10.1128/jvi.02514-09
  20. 20. Adachi O, Kawai T, Takeda K, Matsumoto M, Tsutsui H, et al. (1998) Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9: 143–150. doi: 10.1016/s1074-7613(00)80596-8
  21. 21. Tsai YT, Chang SY, Lee CN, Kao CL (2009) Human TLR3 recognizes dengue virus and modulates viral replication in vitro. Cell Microbiol 11: 604–615. doi: 10.1111/j.1462-5822.2008.01277.x
  22. 22. Wilson JR, de Sessions PF, Leon MA, Scholle F (2008) West Nile virus nonstructural protein 1 inhibits TLR3 signal transduction. J Virol 82: 8262–8271. doi: 10.1128/jvi.00226-08
  23. 23. Baronti C, Sire J, de Lamballerie X, Querat G (2010) Nonstructural NS1 proteins of several mosquito-borne Flavivirus do not inhibit TLR3 signaling. Virology 404: 319–330. doi: 10.1016/j.virol.2010.05.020
  24. 24. Lamkanfi M, Dixit VM (2011) Modulation of inflammasome pathways by bacterial and viral pathogens. J Immunol 187: 597–602. doi: 10.4049/jimmunol.1100229
  25. 25. Ramos HJ, Lanteri MC, Blahnik G, Negash A, Suthar MS, et al. (2012) IL-1beta signaling promotes CNS-intrinsic immune control of West Nile virus infection. PLoS Pathog 8: e1003039 doi:10.1371/journal.ppat.1003039.
  26. 26. Bozza FA, Cruz OG, Zagne SM, Azeredo EL, Nogueira RM, et al. (2008) Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC Infect Dis 8: 86. doi: 10.1186/1471-2334-8-86
  27. 27. Guerrero CD, Arrieta AF, Ramirez ND, Rodriguez LS, Vega R, et al. (2013) High plasma levels of soluble ST2 but not its ligand IL-33 is associated with severe forms of pediatric dengue. Cytokine 61: 766–771. doi: 10.1016/j.cyto.2012.12.024
  28. 28. Wu MF, Chen ST, Yang AH, Lin WW, Lin YL, et al. (2013) CLEC5A is critical for dengue virus-induced inflammasome activation in human macrophages. Blood 121: 95–106. doi: 10.1182/blood-2012-05-430090
  29. 29. Durrant DM, Robinette ML, Klein RS (2013) IL-1R1 is required for dendritic cell-mediated T cell reactivation within the CNS during West Nile virus encephalitis. J Exp Med 210: 503–516. doi: 10.1084/jem.20121897
  30. 30. Kumar M, Verma S, Nerurkar VR (2010) Pro-inflammatory cytokines derived from West Nile virus (WNV)-infected SK-N-SH cells mediate neuroinflammatory markers and neuronal death. J Neuroinflammation 7: 73. doi: 10.1186/1742-2094-7-73